AIM
AGN

Arcadia Investment Management’s Allergan plc AGN Stock Holding History

Arcadia Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-85
Closed -$21K – 394
2017
Q2 		$21K Hold
85
– – 0.01% 289
2017
Q1 		$20K Sell
85
-500
-85% -$116K 0.01% 328
2016
Q4 		$123K Buy
585
+500
+588% +$104K 0.04% 141
2016
Q3 		$20K Sell
85
-5
-6% -$1.22K 0.01% 273
2016
Q2 		$21K Buy
90
+5
+6% +$1.15K 0.01% 333
2016
Q1 		$23K Hold
85
– – 0.01% 214
2015
Q4 		$27K Buy
+85
New +$25.3K 0.01% 204

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Arcadia Investment Management's AGN Position: Q3 2017 in Review

Arcadia Investment Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 85 shares — an estimated $21K sold.

Arcadia Investment Management first reported a position in AGN in Q4 2015 and held it in 7 quarters. The position peaked at $123K in Q4 2016. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Arcadia Investment Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Arcadia Investment Management sold 85 Allergan plc shares in Q3 2017, an estimated $21K.
  • Arcadia Investment Management first reported a position in Allergan plc in Q4 2015 and held it in 7 quarters.
  • Arcadia Investment Management's Allergan plc position peaked at $123K in Q4 2016.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Arcadia Investment Management's 13F filing for Q3 2017, filed 18 Oct 2017.